Columbia Suicide Severity Rating Scale (C-SSRS): A Comprehensive Guide to This Clinical Screening Tool

The Columbia Suicide Severity Rating Scale (C-SSRS) is a structured clinical interview tool designed to assess the severity and type of suicidal ideation and suicidal behavior. Developed at Columbia University by Kelly Posner and colleagues, it was first published in 2007 and has since become one of the most widely adopted suicide risk screening instruments in the world.

Unlike older screening measures that often conflated suicidal thoughts with self-harm behaviors—or treated suicidality as a single yes-or-no variable—the C-SSRS draws a clear, clinically meaningful distinction between suicidal ideation (thoughts about suicide) and suicidal behavior (actions taken toward suicide). This distinction is critical because the clinical implications and required interventions differ substantially depending on whether a person is experiencing passive thoughts of death versus actively planning or attempting suicide.

The C-SSRS was developed with support from the National Institute of Mental Health (NIMH) and has been endorsed by the U.S. Food and Drug Administration (FDA), the Centers for Disease Control and Prevention (CDC), the Substance Abuse and Mental Health Services Administration (SAMHSA), and the World Health Organization (WHO). It is used across clinical trials, emergency departments, primary care settings, schools, military installations, and correctional facilities worldwide.

The C-SSRS measures two primary domains, each with its own structured assessment hierarchy:

1. Suicidal Ideation (Severity)

Suicidal ideation is assessed on a five-level ordinal scale that captures increasing severity:

• Level 1 — Wish to be dead: The person endorses a desire to be dead or not alive, without any specific thoughts of ending their own life.
• Level 2 — Nonspecific active suicidal thoughts: General thoughts of wanting to kill oneself (e.g., "I've thought about killing myself") without a specific plan or method.
• Level 3 — Active suicidal ideation with any methods (not a plan): Thoughts of suicide that include consideration of a method, but without a specific, organized plan.
• Level 4 — Active suicidal ideation with some intent to act: The person has thoughts of killing themselves and reports some degree of intent to follow through, as opposed to simply having the thought.
• Level 5 — Active suicidal ideation with a specific plan and intent: The person has a detailed plan for how they would attempt suicide and expresses intent to carry it out.

Additionally, the ideation section captures intensity features, including frequency of thoughts, duration of each episode, controllability, deterrents, and the reasons for the ideation.

2. Suicidal Behavior

The behavior section classifies any suicide-related actions using clearly defined categories:

• Actual attempt: A potentially self-injurious act committed with at least some intent to die.
• Interrupted attempt: A person is stopped by an outside circumstance before beginning the self-destructive act.
• Aborted attempt: A person begins to take steps toward an attempt but stops themselves before the act.
• Preparatory acts or behavior: Steps taken toward making an attempt, such as gathering pills, writing a note, or giving away possessions.
• Non-suicidal self-injurious behavior: Self-harm without intent to die (this is assessed but categorized separately from suicidal behavior).

If a suicide attempt has occurred, the C-SSRS also assesses the lethality of the attempt and the potential lethality (how dangerous the method could have been regardless of the actual medical outcome).

The C-SSRS was originally developed for use in clinical trials studying psychiatric medications, where the FDA required standardized tracking of treatment-emergent suicidality. However, its utility quickly expanded far beyond this original purpose.

The scale is appropriate for use with:

• Adolescents and adults — The standard version is validated for individuals aged 12 and older. A modified version exists for children as young as 6, though its use in younger populations requires clinician judgment and developmental awareness.
• Psychiatric inpatients and outpatients — It is widely used in hospital settings, crisis stabilization units, and routine outpatient mental health care.
• Primary care patients — Shortened screener versions have been developed for use in medical settings where time is limited.
• Emergency department patients — The C-SSRS helps emergency clinicians rapidly triage suicide risk and determine disposition (e.g., discharge with safety planning versus psychiatric admission).
• Military and veteran populations — The U.S. Department of Defense and the Department of Veterans Affairs have adopted the C-SSRS as a standard screening measure.
• Students — School-based versions are used in educational settings to identify at-risk youth.
• Incarcerated individuals — Correctional facilities use the tool during intake and ongoing monitoring.

The tool is designed to be administered by clinicians, trained paraprofessionals, or researchers. A self-report version also exists for settings where a clinical interview is not feasible, though the clinician-administered version is generally considered more reliable for high-stakes assessments.

The C-SSRS is administered as a brief, structured clinical interview. The full version typically takes 5 to 10 minutes to complete, though the duration depends on the complexity of the individual's presentation and the number of endorsed items that require follow-up.

Several versions of the tool exist to fit different clinical contexts:

• Full C-SSRS (Lifetime/Recent): The comprehensive version assesses both lifetime history of suicidal ideation and behavior and recent experiences (typically since the last visit or within a specified time frame). This version is most commonly used in clinical trials and comprehensive psychiatric evaluations.
• C-SSRS "Since Last Visit" Version: Designed for ongoing monitoring in treatment settings, this version focuses on ideation and behavior occurring since the patient's most recent contact with a clinician.
• C-SSRS Screener: A condensed version with six key questions, designed for rapid screening in emergency departments, primary care, and other non-specialty settings. It can be administered in approximately 1 to 2 minutes.
• Self-Report Version: A questionnaire format that patients can complete independently, useful in research settings or as a preliminary screen before clinical interview.

The interviewer begins by asking about passive ideation ("Have you wished you were dead or wished you could go to sleep and not wake up?") and proceeds through increasingly severe levels of active ideation. If no ideation is endorsed at a given level, the interviewer does not need to ask about higher levels. If suicidal ideation is endorsed, the clinician then assesses the intensity dimensions. Suicidal behavior questions are asked regardless of ideation responses, because some individuals engage in impulsive attempts without prolonged preceding ideation.

Proper administration requires training. The Columbia Lighthouse Project provides free training materials, including didactic videos, instructional guides, and scoring manuals. While the tool is designed to be usable by non-clinicians with appropriate training, clinical judgment remains essential in interpreting the results and making risk management decisions.

The C-SSRS does not produce a single summed total score. Instead, it generates a categorical risk profile based on the highest level of ideation endorsed and any suicidal behaviors present. This approach reflects the clinical reality that suicide risk is multidimensional and cannot be meaningfully reduced to a single number.

Ideation Score: The severity of ideation is rated from 1 to 5 based on the highest level endorsed. Research consistently shows that higher ideation severity—particularly levels 4 and 5 (ideation with intent and plan)—is associated with significantly elevated risk for future suicide attempts.

Ideation Intensity Score: For each endorsed level of ideation, the intensity subscale captures five dimensions rated on 1-to-5 scales: frequency, duration, controllability, deterrents, and reasons for ideation. The intensity total ranges from 2 to 25.

Suicidal Behavior: Any endorsed suicidal behavior (actual attempt, interrupted attempt, aborted attempt, or preparatory behavior) is categorized and dated. A history of any prior suicide attempt is one of the strongest known predictors of future attempts.

Clinical Interpretation:

The screener version uses a simplified triage framework widely adopted in emergency and primary care settings:

• Low risk: No ideation or only wish to be dead (Level 1) with no history of attempt.
• Moderate risk: Active suicidal ideation without plan or intent (Levels 2–3), or past suicide attempt.
• High risk: Active suicidal ideation with intent or plan (Levels 4–5), recent suicidal behavior, or an actual attempt during the assessment period.

It is essential to understand that these categories are decision-support tools, not deterministic predictions. The C-SSRS identifies the nature and severity of current suicidal thinking and past behavior, but it does not predict who will or will not die by suicide. Clinical judgment, consideration of risk and protective factors, and a thorough psychosocial assessment must always accompany the use of any standardized tool.

The C-SSRS has been extensively studied and demonstrates strong psychometric properties across diverse populations and settings.

Predictive Validity: Research published in the American Journal of Psychiatry by Posner and colleagues demonstrated that C-SSRS ideation severity levels significantly predict future suicidal behavior. Specifically, individuals endorsing Level 4 or Level 5 ideation are approximately 5 to 14 times more likely to make a suicide attempt compared to those with no ideation. The behavior classifications also demonstrate strong predictive validity—a history of actual attempt is consistently one of the strongest predictors of future attempts and death by suicide.

Convergent and Divergent Validity: The C-SSRS correlates strongly with other established measures of suicidal ideation, including the Beck Scale for Suicide Ideation (BSS) and the Sheehan Suicidality Tracking Scale (S-STS), while showing appropriate divergence from measures of general depression and anxiety. This supports the claim that it is measuring a distinct construct—suicidality—rather than general distress.

Reliability: Studies demonstrate good to excellent internal consistency for the ideation severity and intensity scales. Inter-rater reliability is strong (intraclass correlation coefficients typically reported above 0.90) when administrators have received standardized training, indicating that different interviewers arrive at consistent classifications for the same patient.

Sensitivity and Specificity: The C-SSRS screener version has demonstrated high sensitivity in emergency department studies, meaning it correctly identifies a high proportion of individuals who are genuinely at risk. Specificity is moderate, which means some individuals may screen positive who are not at imminent risk—a characteristic that is generally acceptable in screening contexts where the cost of missing a true case far outweighs the cost of a false positive.

Cross-Cultural Validation: The C-SSRS has been translated into over 140 languages and has been studied across diverse cultural groups, including populations in the United States, Europe, Asia, Africa, and South America. While the core structure performs consistently, clinicians should remain aware that cultural factors influence how individuals express and report suicidal thoughts.

Despite its widespread adoption and strong evidence base, the C-SSRS has notable limitations that clinicians and researchers should understand:

• It is not a risk prediction tool. The C-SSRS characterizes current and past suicidal ideation and behavior, but it does not produce a probability estimate for future suicide. No existing tool reliably predicts individual suicide events, and the C-SSRS should not be used as if it does.
• It relies on self-report. The accuracy of the C-SSRS depends entirely on the individual's willingness and ability to disclose suicidal thoughts. People who are determined to conceal their suicidality—due to fear of hospitalization, stigma, or other reasons—may deny ideation, producing a falsely reassuring result.
• It does not assess all relevant risk factors. The C-SSRS focuses narrowly on ideation and behavior. It does not systematically evaluate important contextual risk factors such as substance use, access to lethal means, recent losses, social isolation, or psychiatric diagnoses. A comprehensive suicide risk assessment requires integrating C-SSRS results with a broader clinical evaluation.
• Training quality varies. While the tool is designed for use by trained non-clinicians, the quality of administration depends heavily on the adequacy of training. Poorly trained administrators may fail to probe adequately, misclassify responses, or miss nuances in the individual's presentation.
• Temporal limitations. A C-SSRS assessment captures a snapshot in time. Suicidal ideation is dynamic and can fluctuate rapidly, particularly in the context of acute crises, intoxication, or interpersonal conflict. A negative screen does not guarantee safety beyond the moment of assessment.
• Potential for overreliance. In institutional settings where the C-SSRS is mandated as part of protocol, there is a risk that clinicians may use the instrument as a substitute for genuine clinical engagement rather than as one component of a comprehensive assessment. The structured format should complement—not replace—empathic, open-ended clinical dialogue.
• Limited utility in some populations. For individuals with cognitive impairments, severe psychosis, acute intoxication, or very young children, the C-SSRS's structured questions may not be appropriate or reliable without significant modification.

The C-SSRS serves multiple functions across clinical settings, from initial screening to ongoing treatment monitoring.

Emergency Department Triage: Emergency departments use the C-SSRS screener to rapidly classify suicide risk and guide disposition decisions. A patient endorsing Level 5 ideation (active ideation with specific plan and intent) will typically receive an immediate psychiatric evaluation and may be placed on a psychiatric hold, while a patient endorsing only Level 1 ideation (wish to be dead) without behavioral history may be appropriate for discharge with safety planning and outpatient referral.

Inpatient Admission and Monitoring: Psychiatric units administer the C-SSRS at admission, at regular intervals during hospitalization, and at discharge to track changes in suicidal ideation and behavior over time. This longitudinal data informs treatment planning and helps clinicians assess readiness for step-down care.

Outpatient Treatment Planning: In outpatient settings, the C-SSRS guides decisions about treatment intensity, frequency of appointments, need for safety planning, involvement of family members, and referral for higher levels of care. Clinicians use the "Since Last Visit" version to monitor treatment response.

Clinical Trial Safety Monitoring: The C-SSRS was originally developed for this purpose and remains the FDA-recommended measure for prospective assessment of treatment-emergent suicidality in psychiatric drug trials. This application has been critical for detecting whether medications—particularly antidepressants and anticonvulsants—may increase suicidal ideation in certain populations.

Safety Planning: C-SSRS results inform the development of individualized safety plans—structured documents that outline warning signs, coping strategies, sources of support, professionals to contact, and steps to restrict access to lethal means. The specificity of C-SSRS data (e.g., knowing whether a patient has a specific plan or method in mind) directly enhances the relevance and specificity of the safety plan.

Documentation and Communication: The C-SSRS provides standardized language for documenting suicide risk assessments in medical records and communicating risk levels across treatment teams. This standardization reduces ambiguity and improves continuity of care, particularly during transitions between providers or levels of care.

One of the most significant advantages of the C-SSRS is that it is freely available. The tool and all associated training materials can be accessed at no cost through the Columbia Lighthouse Project (https://cssrs.columbia.edu).

Available resources include:

• The full C-SSRS instrument in multiple versions (Lifetime/Recent, Since Last Visit, Screener, Self-Report)
• Free online training modules for clinicians and non-clinical staff
• Administration and scoring guides
• Translations in over 140 languages
• Implementation toolkits for healthcare systems, schools, and community organizations

No licensing fee, permission request, or formal registration is required to use the C-SSRS in clinical practice, research, or community settings. This open-access model has been instrumental in the tool's widespread global adoption.

Organizations planning to implement the C-SSRS should invest in standardized training for all personnel who will administer it, develop clear clinical pathways for responding to positive screens, and establish supervision structures to ensure ongoing fidelity.

If you or someone you know is experiencing suicidal thoughts, it is important to seek help immediately. Suicidal ideation—at any severity level—warrants professional evaluation.

Emergency resources:

• 988 Suicide & Crisis Lifeline: Call or text 988 (available 24/7 in the United States)
• Crisis Text Line: Text HOME to 741741
• Emergency services: Call 911 or go to your nearest emergency department if there is immediate danger
• Veterans Crisis Line: Call 988, then press 1

The C-SSRS is a clinical tool intended for use by trained professionals as part of a comprehensive assessment. It is not designed for self-diagnosis. If you recognize patterns in your own thinking that align with the levels of suicidal ideation described in this article—particularly thoughts involving a method, intent, or plan—this is a strong signal to reach out to a mental health professional or crisis service without delay.

Early intervention saves lives. Suicidal crises are often time-limited, and evidence-based treatments—including safety planning, psychotherapy, and medication management—are effective in reducing suicidal ideation and preventing attempts.